VTRS Q4 2018 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.1B-4.9% YoY

Gross Profit

$1.0B33.0% margin

Operating Income

$233M7.6% margin

Net Income

$51M1.7% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+7.6%

Cash Flow

Operating Cash Flow

$636M

Free Cash Flow

$521M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$32.7B

Total Liabilities

$20.6B

Stockholders' Equity

$12.2B

Cash & Equivalents

$388M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.1B	$3.2B	-4.9%
Gross Profit	$1.0B	$1.3B	-21.6%
Operating Income	$233M	$421M	-44.6%
Net Income	$51M	$244M	-79.0%